Epidemiology and survival trend of adult T‐cell leukemia/lymphoma in the United States-Reference-Cited by-同舟云学术

Epidemiology and survival trend of adult T‐cell leukemia/lymphoma in the United States

Published:2019-11-26 Issue:3 Volume:126 Page:567-574
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Shah Urvi A.¹²^ORCID,Shah Nishi²,Qiao Baozhen³,Acuna‐Villaorduna Ana²,Pradhan Kith⁴,Adrianzen Herrera Diego²,Sica R. Alejandro²,Shastri Aditi²^ORCID,Mantzaris Ioannis²,Derman Olga²,Kornblum Noah²,Braunschweig Ira²,Ye B. Hilda⁵,Verma Amit²,Janakiram Murali²

Affiliation:

1. Department of Medicine Memorial Sloan Kettering Cancer Center New York New York

2. Department of Oncology Albert Einstein College of Medicine/Montefiore Medical Center Bronx New York

3. New York State Cancer Registry New York State Department of Health Albany New York

4. Department of Epidemiology & Population Health Albert Einstein College of Medicine Bronx New York

5. Department of Cell Biology Albert Einstein College of Medicine Bronx New York

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32556

Reference20 articles.

1. Screening transplant donors for HTLV-1 and -2

2. Epidemiological Aspects and World Distribution of HTLV-1 Infection

3. Seroprevalence and Demographic Determinants of Human T-Lymphotropic Virus Type 1 and 2 Infections Among First-Time Blood Donors--United States, 2000-2009

4. Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996

5. Seroprevalence and Epidemiological Correlates of HTLV-I Infection in U.S. Blood Donors

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunophenotypic, genetic, and clinical characterization of adult T-cell leukemia/lymphoma: A single tertiary care center experience in the United States;American Journal of Clinical Pathology;2024-08-30

2. Clinical Features and Survival Outcome in Aggressive-Type Adult T-Cell Leukemia/Lymphoma Patients: Real-Life Experience of a Single Center from an HTLV-1 Endemic Country;Medicina;2024-05-26

3. Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-cell lymphoma;Leukemia & Lymphoma;2024-03-22

4. T-Acute Lymphoblastic Leukemia;D Y Patil Journal of Health Sciences;2024-01

5. Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging Directions;Current Treatment Options in Oncology;2023-06-10